Combination therapy targeting both innate and adaptive immunity improves survival in a pre-clinical model of ovarian cancer
Christina Hartl(Dana-Farber Cancer Institute), Michael S. Goldberg(Dana-Farber Cancer Institute)
Cited by 36
Related Papers
T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity
|Nature Communications|2017|440